Kacey L. Sachen - Concepedia

Author

Kacey L. Sachen

Janssen (United States)

Also Known As

K Sachen, Kacey L. Sachen, Kacey Layn Sachen, Kacey Sachen

Publications

635

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)Université Paris Cité Hôpital Saint-Louis Michigan State University Stanford University

About

Kacey L. Sachen is an author at Janssen (United States) specializing in medicine, immune regulation, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	285
2	Cell Biology	2	2	255
3	Health Sciences	1	1	30
4	Natural Sciences	1	1	242
5	Biochemistry	1	1	242

Kacey L. Sachen

Publications

535

Citations

H-Index

Page 1

	Year	Citations
Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation Pejman Soroosh, Jiejun Wu, Xiaohua Xue, Proceedings of the National Academy of Sciences Lipid PeroxidationImmune RegulationImmunologyInnate ImmunityRedox Biology	2014	242
Self-antigen recognition by follicular lymphoma B-cell receptors Kacey L. Sachen, Michael Strohman, Jonathan Singletary, Blood	2012	89
Modulation of Host Immune Responses by the Cytolethal Distending Toxin of <i>Helicobacter hepaticus</i> Jason S. Pratt, Kacey L. Sachen, Heather D. Wood, Infection and Immunity	2006	85
Tyramide signal amplification for analysis of kinase activity by intracellular flow cytometry Matthew R. Clutter, Garrett C. Heffner, Peter O. Krutzik, Cytometry Part A	2010	44
Genetic Diversity of <i>Campylobacter</i> sp. Isolates from Retail Chicken Products and Humans with Gastroenteritis in Central Michigan Brooke R. Fitch, Kacey L. Sachen, Stacey R. Wilder, Journal of Clinical Microbiology Molecular EpidemiologyPathogen DetectionVeterinary MicrobiologyGenetic DiversityCentral Michigan	2005	30
Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling Kacey L. Sachen, Deepa Hammaker, Indra Sarabia, Frontiers in Immunology	2025	19
Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders Hope Steele, Kacey L. Sachen, Andrew J. McKnight, Frontiers in Immunology	2021	13
P504 Guselkumab, an IL-23p19 subunit–specific monoclonal antibody, binds CD64+ myeloid cells and potently neutralises IL-23 produced from the same cells Raja Atreya, María T. Abreu, James G. Krueger, Journal of Crohn s and Colitis ImmunodeficienciesImmune RegulationImmunologyPathologyImmunologic Mechanism	2023	13

Page 1